INFIQ

Infinity Pharmaceuticals, Inc.

OTC Markets OTCPKUSDEQUITY DELAYED

0.00

■ 0.00 (0.00%)

MARKET · —

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw

Open

0.00

Prev close

0.00

Day high

0.00

Day low

0.00

Volume

109.40K

Market cap

—

P/E (TTM)

—

52W range

— – 0.00

Day trading desk

Current session · delayed

Gap from prior close

+0.00%

Prior close 0.00

VWAP

—

Relative volume

—

Session range

—

0.00 – 0.00

Position in range

—

ATR (14D)

0.00

Daily true range

Prior day high

0.00

PDH

Prior day low

0.00

PDL

Bid / ask spread

—

Quote not published

Session volume

—

Shares traded

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY

Returnvs SPY

0.00% +1.4%

0.00% -3.7%

0.00% -3.1%

0.00% -11.1%

YTD

0.00% -12.3%

+900.00% +880.0%

-99.91% -174.1%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on INFIQ open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Create free account Sign in

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Financial statements

As reported · 2 years

Blank means not reported, not zero

Line item	2022	2021	YoY
Total revenue	$2.59M	$1.86M	+39.6%
Operating revenue	$2.59M	$1.86M	+39.6%
Cost of revenue	$1.56M	$1.12M	+39.6%
Gross profit	$1.03M	$738.00K	+39.6%
Research & development	$32.41M	$31.65M	+2.4%
Selling, general & admin	$13.46M	$14.17M	-5.0%
Total operating expense	$45.87M	$45.82M	+0.1%
Operating income	-$44.84M	-$45.08M	+0.5%
Net interest income	-$180.00K	-$180.00K	0.0%
Pre-tax income	-$44.37M	-$45.26M	+2.0%
Net income	-$44.37M	-$45.26M	+2.0%
Basic EPS	-0.50	-0.53	+5.7%
Diluted EPS	-0.50	-0.53	+5.7%
EBIT	-$44.19M	-$45.08M	+2.0%
EBITDA	-$43.73M	-$44.60M	+2.0%
Basic shares	89.25M	85.60M	+4.3%
Diluted shares	89.25M	85.60M	+4.3%

Line item

2022

2021

YoY

Total revenue

$2.59M

$1.86M

+39.6%

Operating revenue

$2.59M

$1.86M

+39.6%

Cost of revenue

$1.56M

$1.12M

+39.6%

Gross profit

$1.03M

$738.00K

+39.6%

Research & development

$32.41M

$31.65M

+2.4%

Selling, general & admin

$13.46M

$14.17M

-5.0%

Total operating expense

$45.87M

$45.82M

+0.1%

Operating income

-$44.84M

-$45.08M

+0.5%

Net interest income

-$180.00K

0.0%

Pre-tax income

-$44.37M

-$45.26M

+2.0%

Net income

-$44.37M

-$45.26M

+2.0%

Basic EPS

-0.50

-0.53

+5.7%

Diluted EPS

-0.50

-0.53

+5.7%

EBIT

-$44.19M

-$45.08M

+2.0%

EBITDA

-$43.73M

-$44.60M

+2.0%

Basic shares

89.25M

85.60M

+4.3%

Diluted shares

89.25M

85.60M

+4.3%

Line item	2022	2021	YoY
Cash & equivalents	$38.31M	$80.73M	-52.5%
Cash & short-term investments	$38.31M	$80.73M	-52.5%
Total current assets	$40.30M	$82.27M	-51.0%
Property, plant & equipment	$1.50M	$2.31M	-35.1%
Total assets	$42.15M	$84.78M	-50.3%
Total current liabilities	$13.63M	$13.30M	+2.5%
Current debt	—	$897.00K	—
Long-term debt	—	$48.73M	—
Total debt	$917.00K	$1.44M	-36.1%
Total liabilities	$61.20M	$63.21M	-3.2%
Retained earnings	-$855.95M	-$811.58M	-5.5%
Shareholder equity	-$19.05M	$21.57M	-188.3%
Working capital	$26.67M	$68.97M	-61.3%
Net tangible assets	-$19.05M	$21.57M	-188.3%
Shares issued	89.41M	89.16M	+0.3%

Line item

2022

2021

YoY

Cash & equivalents

$38.31M

$80.73M

-52.5%

Cash & short-term investments

$38.31M

$80.73M

-52.5%

Total current assets

$40.30M

$82.27M

-51.0%

Property, plant & equipment

$1.50M

$2.31M

-35.1%

Total assets

$42.15M

$84.78M

-50.3%

Total current liabilities

$13.63M

$13.30M

+2.5%

Current debt

—

$897.00K

—

Long-term debt

—

$48.73M

—

Total debt

$917.00K

$1.44M

-36.1%

Total liabilities

$61.20M

$63.21M

-3.2%

Retained earnings

-$855.95M

-$811.58M

-5.5%

Shareholder equity

-$19.05M

$21.57M

-188.3%

Working capital

$26.67M

$68.97M

-61.3%

Net tangible assets

-$19.05M

$21.57M

-188.3%

Shares issued

89.41M

89.16M

+0.3%

Line item	2022	2021	YoY
Net income	-$44.37M	-$45.26M	+2.0%
Depreciation & amortisation	$458.00K	$480.00K	-4.6%
Stock-based compensation	$3.62M	$2.69M	+34.4%
Change in working capital	-$1.04M	$2.21M	-146.9%
Operating cash flow	-$42.43M	-$40.62M	-4.5%
Capital expenditure	-$17.00K	-$11.00K	-54.5%
Investing cash flow	-$55.00K	$5.49M	-101.0%
Financing cash flow	$73.00K	$87.11M	-99.9%
Free cash flow	-$42.45M	-$40.63M	-4.5%
End cash position	$38.47M	$80.88M	-52.4%

Line item

2022

2021

YoY

Net income

-$44.37M

-$45.26M

+2.0%

Depreciation & amortisation

$458.00K

$480.00K

-4.6%

Stock-based compensation

$3.62M

$2.69M

+34.4%

Change in working capital

-$1.04M

$2.21M

-146.9%

Operating cash flow

-$42.43M

-$40.62M

-4.5%

Capital expenditure

-$17.00K

-$11.00K

-54.5%

Investing cash flow

-$55.00K

$5.49M

-101.0%

Financing cash flow

$73.00K

$87.11M

-99.9%

Free cash flow

-$42.45M

-$40.63M

-4.5%

End cash position

$38.47M

$80.88M

-52.4%

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

0.00

+0.00% from price

SMA 20

0.00

0.00% from price

SMA 50

0.00

+1.83% from price

SMA 100

0.00

+0.91% from price

SMA 200

0.00

+0.45% from price

EMA 12

0.00

+0.01% from price

EMA 26

0.00

+0.18% from price

EMA 50

0.00

+0.55% from price

RSI (14)

51.9

Neutral

MACD (12,26,9)

0.00

Hist -0.00

ATR (14)

0.00

—

Realised vol 30D

0.0%

Annualised

Bollinger upper

0.00

20, 2σ

Bollinger lower

0.00

20, 2σ

50 / 200 cross

Death

0.00 vs 0.00

Trend bias

Above 200

+0.45%

Options chain

Account required

ExpirySpot 0.00

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Risk profile

Daily returns · 1Y window

Beta vs SPY

-4.24

Less volatile than market

Correlation to SPY

-0.05

Largely independent

Realised vol 30D

0.0%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-90.0%

Peak to trough

Max drawdown 5Y

-100.0%

Peak to trough

ATR 14

0.00

Average true range

Beta (reported)

—

5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.